PPBT (Purple Biotech Ltd. American Depositary Shares) Stock Analysis - Analyst Ratings

Purple Biotech Ltd. American Depositary Shares (PPBT) is a publicly traded Healthcare sector company. As of May 21, 2026, PPBT trades at $2.81 with a market cap of $3.51M and a P/E ratio of 0.00. PPBT moved -11.11% today. Year to date, PPBT is -57.03%; over the trailing twelve months it is -87.63%. Its 52-week range spans $2.71 to $139.50. Analyst consensus is buy with an average price target of $30.00. Rallies surfaces PPBT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate PPBT?

1 analysts cover PPBT: 0 strong buy, 1 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $30.00.

PPBT Key Metrics

Key financial metrics for PPBT
MetricValue
Price$2.81
Market Cap$3.51M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$139.50
52-Week Low$2.71
Volume10.14K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

PPBT Analyst Consensus

1 analysts cover PPBT: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $30.00.

Latest PPBT News

Common questions about PPBT

What do analysts rate PPBT?
1 analysts cover PPBT: 0 strong buy, 1 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $30.00.
Does Rallies show PPBT price targets?
Yes. Rallies tracks PPBT analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is PPBT research on Rallies investment advice?
No. Rallies provides research, data, and educational context for PPBT. It does not provide personalized investment advice.
PPBT

PPBT